Choroidal Neovascularization – Pipeline Review, H2 2018 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Choroidal Neovascularization - Pipeline Review, H2 2018" drug pipelines has been added to ResearchAndMarkets.com's offering. Choroidal Neovascularization - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Choroidal Neovascularization (Ophthalmology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descri

Full Story →